\-\ Texto\\:\\ \ \(0\)\
\-\ patient\\ appeared\\ well\\ and\\ did\\ not\\ have\\ abnormal\\ laboratory\\ values\\ on\\ her\\ workup\\.\ \(0\)\
\-\ no\\ treatment\\ or\\ followup\\ are\\ necessary\\,\\ as\\ long\\ as\\,\\ the\\ patient\\ remains\\ asymptomatic\\.\ \(0\)\
\-\ a\\ three\\-phase\\ ct\\ scan\\ of\\ the\\ liver\\ was\\ performed\\.\\ \\ there\\ is\\ a\\ 5\\.6\\ cm\\ focal\\ liver\\ lesion\\ is\\ present\\ within\\ the\\ right\\ lobe\\ of\\ the\\ liver\\ on\\ the\\ ct\\ scan\\.\\ \\ chunky\\ internal\\ calcifications\\ are\\ present\\.\\ \\ there\\ is\\ the\\ suggestion\\ of\\ peripheral\\ enhancement\\ and\\ fill\\ in\\ on\\ delayed\\ images\\.\\ \ \(0\)\
\-\ the\\ red\\ blood\\ cell\\ scan\\ demonstrates\\ abnormal\\ radiotracer\\ accumulation\\ within\\ the\\ anteroinferior\\ aspect\\ of\\ the\\ liver\\,\\ which\\ correlates\\ to\\ the\\ hypodense\\,\\ partially\\ clacified\\ mass\\ identififed\\ on\\ the\\ ct\\ scan\\.\ \(0\)\
\-\ cavernous\\ hemangioma\ \(14\)\
\-\ cavernous\\ hemangioma\ \(14\)\
\-\ hepatocellular\\ carcinoma\ \(28\)\
\-\ adenoma\ \(519\)\
\-\ focal\\ nodular\\ hyperplasia\ \(9\)\
\-\ metastatic\\ lesion\ \(30\)\
\-\ fibrolamellar\\ carcinoma\ \(1\)\
\-\ 46\\-year\\-old\\ female\\ presented\\ to\\ the\\ emergency\\ room\\ with\\ right\\ lower\\ quadrant\\ pain\\.\\ \\ a\\ ct\\ of\\ the\\ abdomen\\ and\\ pelvis\\ was\\ performed\\ at\\ that\\ time\\ \\-\\ but\\,\\ there\\ was\\ no\\ evidence\\ for\\ appendicitis\\ on\\ the\\ scan\\.\\ \\ however\\,\\ a\\ liver\\ lesion\\ was\\ incidentally\\ found\\ and\\ the\\ patient\\ was\\ referred\\ for\\ further\\ imaging\\.\ \(0\)\
\-\ cavernous\\ malformations\\ \\(hemangiomas\\)\\ are\\ the\\ most\\ common\\ benign\\ tumor\\ affecting\\ the\\ liver\\ with\\ a\\ reported\\ incidence\\ of\\ approximately\\ 2\\%\\.\\ \\ the\\ increased\\ use\\ of\\ noninvasive\\ imaging\\ has\\ lead\\ to\\ an\\ increased\\ detection\\ of\\ asymptomatic\\ lesions\\,\\ such\\ as\\ in\\ this\\ case\\.\\ \\ hepatic\\ hemangiomas\\ can\\ occur\\ at\\ any\\ age\\,\\ but\\ are\\ more\\ common\\ in\\ older\\ patients\\,\\ with\\ female\\-to\\-male\\ ratio\\ of\\ 4\\-6\\:1\\.\\ \\ \\ female\\ patients\\ tend\\ to\\ present\\ at\\ a\\ younger\\ age\\ and\\ with\\ larger\\ tumors\\.\\ \\ there\\ is\\ no\\ association\\ with\\ oral\\ contraceptive\\ use\\,\\ as\\ with\\ hepatic\\ adenomas\\.\ \(0\)\
\-\ hemangiomas\\ are\\ composed\\ of\\ irregular\\ or\\ atypical\\ masses\\ of\\ blood\\ vessels\\.\\ \\ the\\ etiology\\ is\\ unknown\\.\\ \\ the\\ classic\\ ct\\ appearance\\ is\\ that\\ of\\ a\\ hypodense\\ lesion\\ that\\ enhances\\ gradually\\ with\\ centripedal\\ fill\\ in\\ over\\ time\\.\\ \\ the\\ differential\\ diagnosis\\ for\\ hemangiomas\\ includes\\ other\\ benign\\ or\\ malignant\\ hepatic\\ lesions\\ such\\ as\\ focal\\ nodular\\ hyperplasia\\,\\ hepatic\\ adenoma\\,\\ hepatic\\ cysts\\,\\ metastatic\\ disease\\,\\ or\\ hepatocellular\\ carcinoma\\.\\ \\ when\\ the\\ three\\-phase\\ ct\\ appearance\\ of\\ a\\ hepatic\\ lesion\\ is\\ not\\ typical\\ for\\ a\\ hemangioma\\,\\ further\\ imaging\\ with\\ a\\ nuclear\\ medicine\\ tagged\\ red\\ blood\\ cell\\ scan\\ can\\ be\\ performed\\ for\\ more\\ definitive\\ diagnosis\\.\\ \\ this\\ case\\ demonstrates\\ a\\ slightly\\ atypical\\ appearance\\ of\\ a\\ hemngioma\\ with\\ internal\\ calcifications\\.\\ \\ further\\ imaging\\ with\\ the\\ nuclear\\ medicine\\ scan\\ gives\\ a\\ more\\ definitive\\ diagnosis\\.\ \(0\)\
\-\ unless\\ the\\ lesion\\ is\\ large\\ \\(greater\\ than\\ 10\\ cm\\)\\ or\\ there\\ is\\ evidence\\ of\\ bleeding\\,\\ no\\ further\\ work\\ up\\ or\\ treatment\\ is\\ typically\\ required\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ hepatic\\:\\ 0\\.049220611749048446\ \(0\)\
\-\ hemangiomas\\:\\ 0\\.04891044471264384\ \(0\)\
\-\ liver\\:\\ 0\\.04063753808045136\ \(0\)\
\-\ scan\\:\\ 0\\.03849632235179506\ \(0\)\
\-\ three\\-phase\\:\\ 0\\.03158440586166062\ \(0\)\
\-\ cavernous\\:\\ 0\\.027334401103771593\ \(0\)\
\-\ hemangioma\\:\\ 0\\.02633314586346471\ \(0\)\
\-\ fill\\:\\ 0\\.02573169011079677\ \(0\)\
\-\ further\\:\\ 0\\.02498799210850812\ \(0\)\
\-\ lesion\\:\\ 0\\.024007658289661442\ \(0\)\
\-\ hepatocellular\\:\\ 0\\.022637692532670672\ \(0\)\
\-\ hypodense\\:\\ 0\\.020932591020345667\ \(0\)\
\-\ red\\:\\ 0\\.020500274010468535\ \(0\)\
\-\ nuclear\\:\\ 0\\.02027034104230917\ \(0\)\
\-\ clacified\\:\\ 0\\.020265559595325285\ \(0\)\
\-\ identififed\\:\\ 0\\.020265559595325285\ \(0\)\
\-\ female\\-to\\-male\\:\\ 0\\.020265559595325285\ \(0\)\
\-\ 4\\-6\\:1\\.\\:\\ 0\\.020265559595325285\ \(0\)\
\-\ centripedal\\:\\ 0\\.020265559595325285\ \(0\)\
\-\ hemngioma\\:\\ 0\\.020265559595325285\ \(0\)\
\-\ definitive\\:\\ 0\\.019404131373939808\ \(0\)\
\-\ hyperplasia\\:\\ 0\\.019357922933234052\ \(0\)\
\-\ medicine\\:\\ 0\\.01863606661686778\ \(0\)\
\-\ imaging\\:\\ 0\\.01840987424786761\ \(0\)\
\-\ 46\\-year\\-old\\:\\ 0\\.017740014104134227\ \(0\)\
\-\ atypical\\:\\ 0\\.017027727060275655\ \(0\)\
\-\ appearance\\:\\ 0\\.01685452811541132\ \(0\)\
\-\ focal\\:\\ 0\\.016830990373368288\ \(0\)\
\-\ carcinoma\\:\\ 0\\.016702949448385285\ \(0\)\
\-\ ct\\:\\ 0\\.016486946943338524\ \(0\)\
\-\ nodular\\:\\ 0\\.016480045090169707\ \(0\)\
\-\ performed\\:\\ 0\\.01643157469811944\ \(0\)\
\-\ adenoma\\:\\ 0\\.016406870583016146\ \(0\)\
\-\ 5\\.6\\:\\ 0\\.016146572309743548\ \(0\)\
\-\ anteroinferior\\:\\ 0\\.016146572309743548\ \(0\)\
\-\ contraceptive\\:\\ 0\\.016146572309743548\ \(0\)\
\-\ blood\\:\\ 0\\.01608559360351241\ \(0\)\
\-\ use\\:\\ 0\\.015528455701348517\ \(0\)\
\-\ noninvasive\\:\\ 0\\.015214468612943169\ \(0\)\
\-\ as\\:\\ 0\\.014857212711426756\ \(0\)\
\-\ chunky\\:\\ 0\\.014753156669352018\ \(0\)\
\-\ more\\:\\ 0\\.014739146960773561\ \(0\)\
\-\ there\\:\\ 0\\.014617420189252743\ \(0\)\
\-\ calcifications\\:\\ 0\\.014607649446587368\ \(0\)\
\-\ fibrolamellar\\:\\ 0\\.014198761136439631\ \(0\)\
\-\ tagged\\:\\ 0\\.014040156834170776\ \(0\)\
\-\ or\\:\\ 0\\.013814106882258035\ \(0\)\
\-\ benign\\:\\ 0\\.013558852262221616\ \(0\)\
\-\ diagnosis\\:\\ 0\\.013532547108830482\ \(0\)\
\-\ are\\:\\ 0\\.01338935485666209\ \(0\)\
\-\ present\\:\\ 0\\.013310405199528834\ \(0\)\
\-\ asymptomatic\\:\\ 0\\.013280884588487757\ \(0\)\
\-\ internal\\:\\ 0\\.013171843086798949\ \(0\)\
\-\ adenomas\\:\\ 0\\.013057526915028388\ \(0\)\
\-\ gives\\:\\ 0\\.013057526915028388\ \(0\)\
\-\ is\\:\\ 0\\.012926224790453463\ \(0\)\
\-\ correlates\\:\\ 0\\.012775682496425323\ \(0\)\
\-\ such\\:\\ 0\\.012281989838348746\ \(0\)\
\-\ composed\\:\\ 0\\.012027585024161812\ \(0\)\
\-\ age\\:\\ 0\\.011958208393307156\ \(0\)\
\-\ suggestion\\:\\ 0\\.011903292561471523\ \(0\)\
\-\ a\\:\\ 0\\.011852407870440958\ \(0\)\
\-\ younger\\:\\ 0\\.011464085120637709\ \(0\)\
\-\ detection\\:\\ 0\\.011414645568405608\ \(0\)\
\-\ gradually\\:\\ 0\\.011414645568405608\ \(0\)\
\-\ was\\:\\ 0\\.011359511749582607\ \(0\)\
\-\ abnormal\\:\\ 0\\.011205021794551316\ \(0\)\
\-\ tend\\:\\ 0\\.011138451748079026\ \(0\)\
\-\ time\\:\\ 0\\.011097017136732472\ \(0\)\
\-\ malformations\\:\\ 0\\.010971188864671145\ \(0\)\
\-\ affecting\\:\\ 0\\.01093120784694271\ \(0\)\
\-\ ratio\\:\\ 0\\.010891910298990296\ \(0\)\
\-\ appeared\\:\\ 0\\.01070490882898121\ \(0\)\
\-\ unless\\:\\ 0\\.01063416938377028\ \(0\)\
\-\ cell\\:\\ 0\\.010612600972788442\ \(0\)\
\-\ cm\\:\\ 0\\.010537729277319476\ \(0\)\
\-\ lesions\\:\\ 0\\.010517519569397461\ \(0\)\
\-\ accumulation\\:\\ 0\\.010466295510172833\ \(0\)\
\-\ evidence\\:\\ 0\\.010300885440767254\ \(0\)\
\-\ common\\:\\ 0\\.01028168833083401\ \(0\)\
\-\ remains\\:\\ 0\\.010220851888504544\ \(0\)\
\-\ that\\:\\ 0\\.010179177438336712\ \(0\)\
\-\ patients\\:\\ 0\\.010168159077544946\ \(0\)\
\-\ workup\\:\\ 0\\.010107305324528505\ \(0\)\
\-\ \\,\\:\\ 0\\.009957151835118616\ \(0\)\
\-\ older\\:\\ 0\\.009895767626321031\ \(0\)\
\-\ metastatic\\:\\ 0\\.009890158177545242\ \(0\)\
\-\ values\\:\\ 0\\.009821203774014929\ \(0\)\
\-\ increased\\:\\ 0\\.009611424284136348\ \(0\)\
\-\ association\\:\\ 0\\.009545009953688347\ \(0\)\
\-\ larger\\:\\ 0\\.009459857604997889\ \(0\)\
\-\ lead\\:\\ 0\\.009418435753267593\ \(0\)\
\-\ followup\\:\\ 0\\.009377747070280466\ \(0\)\
\-\ enhances\\:\\ 0\\.009279068806563146\ \(0\)\
\-\ work\\:\\ 0\\.009203066824354207\ \(0\)\
\-\ radiotracer\\:\\ 0\\.009165987785434936\ \(0\)\
\-\ incidence\\:\\ 0\\.00900615775635767\ \(0\)\
\-\ partially\\:\\ 0\\.008989065851788663\ \(0\)\
\-\ appendicitis\\:\\ 0\\.008938539629446652\ \(0\)\
\-\ can\\:\\ 0\\.008911367137788825\ \(0\)\
\-\ incidentally\\:\\ 0\\.008905462072085504\ \(0\)\
\-\ necessary\\:\\ 0\\.008701334488676006\ \(0\)\
\-\ case\\:\\ 0\\.00859542267984952\ \(0\)\
\-\ demonstrates\\:\\ 0\\.008582166444382464\ \(0\)\
\-\ bleeding\\:\\ 0\\.008527753908197511\ \(0\)\
\-\ room\\:\\ 0\\.008445643373480088\ \(0\)\
\-\ for\\:\\ 0\\.008380553432674886\ \(0\)\
\-\ but\\:\\ 0\\.008379325521993277\ \(0\)\
\-\ on\\:\\ 0\\.008320586349027909\ \(0\)\
\-\ etiology\\:\\ 0\\.008314991707357867\ \(0\)\
\-\ oral\\:\\ 0\\.00827720153185635\ \(0\)\
\-\ female\\:\\ 0\\.008077058719300385\ \(0\)\
\-\ delayed\\:\\ 0\\.007995357113253287\ \(0\)\
\-\ at\\:\\ 0\\.007984573467804365\ \(0\)\
\-\ treatment\\:\\ 0\\.00795226188322247\ \(0\)\
\-\ slightly\\:\\ 0\\.007940750018981776\ \(0\)\
\-\ includes\\:\\ 0\\.007919265277790426\ \(0\)\
\-\ no\\:\\ 0\\.00791213012141427\ \(0\)\
\-\ vessels\\:\\ 0\\.007908597738580075\ \(0\)\
\-\ typical\\:\\ 0\\.007876888952068959\ \(0\)\
\-\ irregular\\:\\ 0\\.007835279660934205\ \(0\)\
\-\ cysts\\:\\ 0\\.007695306397313487\ \(0\)\
\-\ unknown\\:\\ 0\\.007666389656608061\ \(0\)\
\-\ the\\:\\ 0\\.007627546742269009\ \(0\)\
\-\ classic\\:\\ 0\\.007527022709903614\ \(0\)\
\-\ within\\:\\ 0\\.00749485705005095\ \(0\)\
\-\ emergency\\:\\ 0\\.007438594478115576\ \(0\)\
\-\ referred\\:\\ 0\\.007412715961966992\ \(0\)\
\-\ tumors\\:\\ 0\\.007378658293495405\ \(0\)\
\-\ greater\\:\\ 0\\.007378658293495405\ \(0\)\
\-\ occur\\:\\ 0\\.007370222135129973\ \(0\)\
\-\ laboratory\\:\\ 0\\.007239291346790956\ \(0\)\
\-\ reported\\:\\ 0\\.007161091610519108\ \(0\)\
\-\ pelvis\\:\\ 0\\.0071381411645784565\ \(0\)\
\-\ peripheral\\:\\ 0\\.0071078926942853265\ \(0\)\
\-\ malignant\\:\\ 0\\.007100392359492646\ \(0\)\
\-\ did\\:\\ 0\\.007092916416075687\ \(0\)\
\-\ required\\:\\ 0\\.007070633360430492\ \(0\)\
\-\ typically\\:\\ 0\\.006934312113806833\ \(0\)\
\-\ quadrant\\:\\ 0\\.006913507894220815\ \(0\)\
\-\ long\\:\\ 0\\.00677292301340856\ \(0\)\
\-\ masses\\:\\ 0\\.006640442294243878\ \(0\)\
\-\ 10\\:\\ 0\\.006622124662866461\ \(0\)\
\-\ differential\\:\\ 0\\.0062366892628802975\ \(0\)\
\-\ found\\:\\ 0\\.006190863481499108\ \(0\)\
\-\ any\\:\\ 0\\.006185827662235158\ \(0\)\
\-\ aspect\\:\\ 0\\.00617078605628358\ \(0\)\
\-\ approximately\\:\\ 0\\.006077742130012834\ \(0\)\
\-\ patient\\:\\ 0\\.005907530558044055\ \(0\)\
\-\ her\\:\\ 0\\.005906693467781461\ \(0\)\
\-\ abdomen\\:\\ 0\\.005819274167576313\ \(0\)\
\-\ not\\:\\ 0\\.005677327226399703\ \(0\)\
\-\ when\\:\\ 0\\.00562604882210576\ \(0\)\
\-\ however\\:\\ 0\\.0054698116220622305\ \(0\)\
\-\ presented\\:\\ 0\\.0053548451379825494\ \(0\)\
\-\ lobe\\:\\ 0\\.005285805397525365\ \(0\)\
\-\ up\\:\\ 0\\.005282407243802812\ \(0\)\
\-\ enhancement\\:\\ 0\\.0052654914163747955\ \(0\)\
\-\ than\\:\\ 0\\.005147238746938561\ \(0\)\
\-\ over\\:\\ 0\\.0050014772187125574\ \(0\)\
\-\ \\%\\:\\ 0\\.00458234720309427\ \(0\)\
\-\ tumor\\:\\ 0\\.004579844371519106\ \(0\)\
\-\ most\\:\\ 0\\.004535253199374888\ \(0\)\
\-\ other\\:\\ 0\\.004527904709660802\ \(0\)\
\-\ well\\:\\ 0\\.004443864259698048\ \(0\)\
\-\ this\\:\\ 0\\.004419021670409807\ \(0\)\
\-\ lower\\:\\ 0\\.004418073722675546\ \(0\)\
\-\ large\\:\\ 0\\.0042954998432898385\ \(0\)\
\-\ have\\:\\ 0\\.0042538806399197516\ \(0\)\
\-\ 2\\:\\ 0\\.004230125279334589\ \(0\)\
\-\ \\-\\:\\ 0\\.004210870020019226\ \(0\)\
\-\ right\\:\\ 0\\.004145433145335249\ \(0\)\
\-\ of\\:\\ 0\\.004017372441309946\ \(0\)\
\-\ to\\:\\ 0\\.003927063066142402\ \(0\)\
\-\ in\\:\\ 0\\.0038749170587609647\ \(0\)\
\-\ images\\:\\ 0\\.0037684227401134575\ \(0\)\
\-\ has\\:\\ 0\\.003688965449412133\ \(0\)\
\-\ which\\:\\ 0\\.0036669990511322957\ \(0\)\
\-\ \\(\\:\\ 0\\.003321203339052232\ \(0\)\
\-\ \\)\\:\\ 0\\.0032806330671876095\ \(0\)\
\-\ disease\\:\\ 0\\.0032108908993464464\ \(0\)\
\-\ be\\:\\ 0\\.0030293258007906415\ \(0\)\
\-\ mass\\:\\ 0\\.002732094268844976\ \(0\)\
\-\ an\\:\\ 0\\.0027164709523786893\ \(0\)\
\-\ with\\:\\ 0\\.002689751174480224\ \(0\)\
\-\ pain\\:\\ 0\\.0023990992357028383\ \(0\)\
\-\ and\\:\\ 0\\.00206906903140481\ \(0\)\
\-\ \\.\\:\\ 0\\.001795378837107168\ \(0\)\
